Sight Sciences (SGHT) EBIT Margin (2020 - 2026)
Sight Sciences' (SGHT) quarterly EBIT Margin came in at 63.02% in Q1 2026, up 1614.0% year-on-year from 3.68% in Q1 2025, and down 250.12% quarter-over-quarter from 18.0% in Q4 2025.
Sight Sciences (SGHT) EBIT Margin (2020 - 2026) Analysis & Trends
Sight Sciences' EBIT Margin history runs 7 years deep, the most recent figure standing at 63.02% for Q1 2026.
- On a quarterly basis, EBIT Margin rose 1614.0% year-over-year to 63.02% in Q1 2026; TTM through Mar 2026 was 44.82%, a 1877.0% increase from a year earlier, with the FY2025 full-year figure at 47.95%, up 1532.0% from the prior year.
- EBIT Margin eased to 63.02% in Q1 2026 per SGHT's latest filing, from 18.0% in the prior quarter.
- Across five years, EBIT Margin topped out at 18.0% in Q4 2025 and bottomed at 149.14% in Q1 2022.
- The 5-year median for EBIT Margin is 64.71% (2023), against an average of 75.27%.
- Across the five-year window, EBIT Margin slumped 4435 bps in 2022 and jumped 6800 bps in 2023, its largest moves.
- Year by year, EBIT Margin stood at 83.01% in 2022, then rose by 29 bps to 59.25% in 2023, then fell by 6 bps to 62.54% in 2024, then soared by 71 bps to 18.0% in 2025, then slumped by 250 bps to 63.02% in 2026.
- Per Business Quant, the three latest SGHT EBIT Margin figures stand at 63.02% (Q1 2026), 18.0% (Q4 2025), and 39.71% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | -63.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.02% |
| Dec 31, 2025 | -18.00% |
| Sep 30, 2025 | -39.71% |
| Jun 30, 2025 | -59.64% |
| Mar 31, 2025 | -79.16% |
| Dec 31, 2024 | -62.54% |
| Sep 30, 2024 | -55.71% |
| Jun 30, 2024 | -59.20% |
| Mar 31, 2024 | -76.42% |
| Dec 31, 2023 | -59.25% |
| Sep 30, 2023 | -67.02% |
| Jun 30, 2023 | -64.71% |
| Mar 31, 2023 | -93.33% |
| Dec 31, 2022 | -83.01% |
| Sep 30, 2022 | -116.96% |
| Jun 30, 2022 | -132.71% |
| Mar 31, 2022 | -149.14% |
| Dec 31, 2021 | -100.21% |
| Sep 30, 2021 | -107.09% |
| Jun 30, 2021 | -88.36% |